Main Listing & Freefloat11 Nov 2020 09:48
We forget its a main listed stock with 40% free float, excellent RNS "We are excited to team up with the Mayo Clinic to significantly expand the diagnostic utility of our core applications. This collaboration provides key clinical input to further enhance the design and guide development of IB Trax," said Michael Schmainda, CEO of IB."